Clinical Trial Update: Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating an immunologic therapy targeting the ESR1 receptor in hormone receptor–expressing metastatic breast cancer is currently recruiting at t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ESR1-targeted immunologic therapy

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer Metastatic Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Status: RECRUITING